# SAGE Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sage-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Website: www.sagerx.com
- Total disclosed funding: $83M
- Latest round: Series C (Mar 13, 2014)
- Investors on record: 5

## About

Established in 2010 and based in Massachusetts, US, SAGE Therapeutics develops medicines for debilitating and disabling central nervous system disorders.

## Funding rounds

- Series C, Mar 13, 2014, $38M — ARCH Venture Partners, OrbiMed Advisors, Third Rock Ventures, Foresite Capital, EcoR1 Capital
- Series B, Oct 16, 2013, $10M — ARCH Venture Partners, Third Rock Ventures
- Series A, Oct 18, 2011, $35M — Third Rock Ventures

## Investors

- Third Rock Ventures (https://capitalatlas.ai/funds/third-rock-ventures) — Series A, Series B, Series C
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B, Series C
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series C
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series C
- EcoR1 Capital (https://capitalatlas.ai/funds/ecor1-capital) — Series C